Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kohichi ANDO
Comparison of Biweekly and Triweekly Therapy With Docetaxel and Irinotecan for Refractory or Relapsed Advanced Non-Small-Cell Lung Cancer
The Showa University Journal of Medical Sciences
Related publications
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-Cell Lung Cancer
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Analysis of Continuous First‑line Treatment With Docetaxel and Carboplatin for Advanced Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Phase I Study of Celecoxib With Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients With Unresectable Locally Advanced Non-Small Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
Phase II Study of S-1 and Docetaxel for Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Phase II Trial of Docetaxel and Ifosfamide for Patients With Platinum-Resistant or Refractory Non-Small Cell Lung Cancer in a Salvage Setting
Cancer Research and Treatment
Cancer Research
Oncology
Single Agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study
Research in Oncology
Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Maintenance Therapy and Advanced Non–Small-Cell Lung Cancer: A Skeptic's View
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients
Korean Journal of Internal Medicine
Internal Medicine
